Screener
Tempest Therapeutics TPST Q1 2026 earnings
Reported May 15, 2026 · Before market open
EPS-$0.51Miss by $0.23
EPS estimate-$0.28
Next report
Nov 4, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Tempest Therapeutics report Q1 2026 earnings?
- Tempest Therapeutics (TPST) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Tempest Therapeutics's Q1 2026 revenue and EPS?
- Tempest Therapeutics reported eps of $-0.51 for Q1 2026.
- Did Tempest Therapeutics beat estimates in Q1 2026?
- EPS missed the consensus estimate of $-0.28 by $0.23.
- How did Tempest Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 83.9% from $-3.16.
- Where can I find Tempest Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-224156) and the 10-Q periodic report (0001193125-26-224289) directly on SEC EDGAR. The filing index links above go to sec.gov.
